Selected research
Market Structure
Global Gadoxetic Acid Disodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gadoxetic Acid Disodium Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gadoxetic Acid Disodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gadoxetic Acid Disodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gadoxetic Acid Disodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gadoxetic Acid Disodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gadoxetic Acid Disodium Injection include CTTQ, Kelun Pharmaceutical, Brilliant Pharmaceutical and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gadoxetic Acid Disodium Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gadoxetic Acid Disodium Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gadoxetic Acid Disodium Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadoxetic Acid Disodium Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Gadoxetic Acid Disodium Injection Segment by Company
CTTQ
Kelun Pharmaceutical
Brilliant Pharmaceutical
Bayer
Gadoxetic Acid Disodium Injection Segment by Type
Single Injection
Multiple Injection
Gadoxetic Acid Disodium Injection Segment by Application
Hospital
Clinic
Others
Gadoxetic Acid Disodium Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadoxetic Acid Disodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadoxetic Acid Disodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadoxetic Acid Disodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gadoxetic Acid Disodium Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gadoxetic Acid Disodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gadoxetic Acid Disodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gadoxetic Acid Disodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Single Injection
- Multiple Injection
Applications
- Hospital
- Clinic
- Others
Companies covered
- CTTQ
- Kelun Pharmaceutical
- Brilliant Pharmaceutical
- Bayer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gadoxetic Acid Disodium Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gadoxetic Acid Disodium Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gadoxetic Acid Disodium Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gadoxetic Acid Disodium Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gadoxetic Acid Disodium Injection Market Dynamics
- 2.1 Gadoxetic Acid Disodium Injection Industry Trends
- 2.2 Gadoxetic Acid Disodium Injection Industry Drivers
- 2.3 Gadoxetic Acid Disodium Injection Industry Opportunities and Challenges
- 2.4 Gadoxetic Acid Disodium Injection Industry Restraints
3 Gadoxetic Acid Disodium Injection Market by Manufacturers
- 3.1 Global Gadoxetic Acid Disodium Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Gadoxetic Acid Disodium Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Gadoxetic Acid Disodium Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gadoxetic Acid Disodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gadoxetic Acid Disodium Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gadoxetic Acid Disodium Injection Manufacturers, Product Type & Application
- 3.7 Global Gadoxetic Acid Disodium Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gadoxetic Acid Disodium Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gadoxetic Acid Disodium Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Gadoxetic Acid Disodium Injection Tier 1, Tier 2, and Tier 3
4 Gadoxetic Acid Disodium Injection Market by Type
- 4.1 Gadoxetic Acid Disodium Injection Type Introduction
- 4.1.1 Single Injection
- 4.1.2 Multiple Injection
- 4.2 Global Gadoxetic Acid Disodium Injection Sales by Type
- 4.2.1 Global Gadoxetic Acid Disodium Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gadoxetic Acid Disodium Injection Sales by Type (2021-2032)
- 4.2.3 Global Gadoxetic Acid Disodium Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Gadoxetic Acid Disodium Injection Revenue by Type
- 4.3.1 Global Gadoxetic Acid Disodium Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gadoxetic Acid Disodium Injection Revenue by Type (2021-2032)
- 4.3.3 Global Gadoxetic Acid Disodium Injection Revenue Market Share by Type (2021-2032)
5 Gadoxetic Acid Disodium Injection Market by Application
- 5.1 Gadoxetic Acid Disodium Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Gadoxetic Acid Disodium Injection Sales by Application
- 5.2.1 Global Gadoxetic Acid Disodium Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gadoxetic Acid Disodium Injection Sales by Application (2021-2032)
- 5.2.3 Global Gadoxetic Acid Disodium Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Gadoxetic Acid Disodium Injection Revenue by Application
- 5.3.1 Global Gadoxetic Acid Disodium Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gadoxetic Acid Disodium Injection Revenue by Application (2021-2032)
- 5.3.3 Global Gadoxetic Acid Disodium Injection Revenue Market Share by Application (2021-2032)
6 Global Gadoxetic Acid Disodium Injection Sales by Region
- 6.1 Global Gadoxetic Acid Disodium Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gadoxetic Acid Disodium Injection Sales by Region (2021-2032)
- 6.2.1 Global Gadoxetic Acid Disodium Injection Sales by Region (2021-2026)
- 6.2.2 Global Gadoxetic Acid Disodium Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gadoxetic Acid Disodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gadoxetic Acid Disodium Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gadoxetic Acid Disodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gadoxetic Acid Disodium Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gadoxetic Acid Disodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gadoxetic Acid Disodium Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gadoxetic Acid Disodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gadoxetic Acid Disodium Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gadoxetic Acid Disodium Injection Revenue by Region
- 7.1 Global Gadoxetic Acid Disodium Injection Revenue by Region
- 7.1.1 Global Gadoxetic Acid Disodium Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gadoxetic Acid Disodium Injection Revenue by Region (2021-2026)
- 7.1.3 Global Gadoxetic Acid Disodium Injection Revenue by Region (2027-2032)
- 7.1.4 Global Gadoxetic Acid Disodium Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gadoxetic Acid Disodium Injection Revenue (2021-2032)
- 7.2.2 North America Gadoxetic Acid Disodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gadoxetic Acid Disodium Injection Revenue (2021-2032)
- 7.3.2 Europe Gadoxetic Acid Disodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gadoxetic Acid Disodium Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gadoxetic Acid Disodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gadoxetic Acid Disodium Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gadoxetic Acid Disodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CTTQ
- 8.1.1 CTTQ Company Information
- 8.1.2 CTTQ Business Overview
- 8.1.3 CTTQ Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CTTQ Gadoxetic Acid Disodium Injection Product Portfolio
- 8.1.5 CTTQ Recent Developments
- 8.2 Kelun Pharmaceutical
- 8.2.1 Kelun Pharmaceutical Company Information
- 8.2.2 Kelun Pharmaceutical Business Overview
- 8.2.3 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Kelun Pharmaceutical Gadoxetic Acid Disodium Injection Product Portfolio
- 8.2.5 Kelun Pharmaceutical Recent Developments
- 8.3 Brilliant Pharmaceutical
- 8.3.1 Brilliant Pharmaceutical Company Information
- 8.3.2 Brilliant Pharmaceutical Business Overview
- 8.3.3 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Brilliant Pharmaceutical Gadoxetic Acid Disodium Injection Product Portfolio
- 8.3.5 Brilliant Pharmaceutical Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer Gadoxetic Acid Disodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer Gadoxetic Acid Disodium Injection Product Portfolio
- 8.4.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gadoxetic Acid Disodium Injection Value Chain Analysis
- 9.1.1 Gadoxetic Acid Disodium Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gadoxetic Acid Disodium Injection Production Mode & Process
- 9.2 Gadoxetic Acid Disodium Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gadoxetic Acid Disodium Injection Distributors
- 9.2.3 Gadoxetic Acid Disodium Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst